Biologically, the contribution of other risk factors beyond smoking is fully supported by the findings of the differing APOBEC B3 mutation signature (Cytidine deaminase driven signature) that predominates in bladder cancer [39], while lung cancer is more typically characterized by the transversion mutation type [40]. This evidence concerns the gene IGKV4-1 and urinary bladder cancer.